Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
MIST
MIST
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
MIST News
Milestone Pharmaceuticals Shares Drop 9% Following Disappointing Earnings Report
May 13 2026
Fool
Milestone Pharmaceuticals Reports Q1 2026 Earnings with Early Commercial Success
May 13 2026
seekingalpha
Milestone Pharmaceuticals Reports Q1 Earnings Miss
May 13 2026
seekingalpha
Milestone Pharmaceuticals to Announce Q1 Earnings on May 13
May 12 2026
seekingalpha
Milestone Pharmaceuticals Launches CARDAMYST Registry Study
Apr 10 2026
Newsfilter
Milestone Pharmaceuticals Reports Q4 and FY 2025 Results with CARDAMYST Updates
Mar 23 2026
NASDAQ.COM
Milestone Pharmaceuticals Earnings Report Preview
Mar 20 2026
Newsfilter
Milestone Pharmaceuticals Reports Q4 2025 Earnings and CARDAMYST Launch
Mar 20 2026
Yahoo Finance
Milestone Pharmaceuticals Reports FY Results
Mar 20 2026
seekingalpha
Major Earnings Reports Expected on Friday
Mar 19 2026
seekingalpha
CARDAMYST Nasal Spray Now Available at Retail Pharmacies
Jan 26 2026
Newsfilter
Milestone Pharmaceuticals (MIST) Receives EMA Review for Etripamil Nasal Spray
Jan 07 2026
NASDAQ.COM
Aptar Launches CARDAMYST Nasal Spray to Address Needs of 2 Million PSVT Patients
Dec 17 2025
Businesswire
Aptar Launches CARDAMYST Nasal Spray for PSVT Treatment
Dec 17 2025
Newsfilter
MIST Achieves Landmark Approval: FDA Greenlights First Self-Administered Nasal Spray for PSVT
Dec 13 2025
NASDAQ.COM
FDA Grants Approval for Milestone Pharma's CARDAMYST, the First Self-Administered Therapy for PSVT
Dec 13 2025
NASDAQ.COM
Show More News
